How a lab and its model animals changed science August 13, 2019 The natural history of science at Cold Spring Harbor Laboratory through the lens of animal research.
Cancer cell’s “self eating” tactic may be its weakness July 1, 2019 Pancreatic cancer cells are eating their own mitochondria to survive and spread. New research reveals how, hinting at a possible new drug target.
Sugars that coat proteins are a possible drug target for pancreatitis June 20, 2019 CA19-9, a complex sugar structure coating proteins, represents a possible drug target for treatment of pancreatitis and prevention of pancreatic cancer.
Special fibroblasts help pancreatic cancer cells evade immune detection June 13, 2019 Researchers found a specific type of cancer-associated fibroblast interacts with the immune system to help pancreatic cancer cells stay under the radar.
One experiment: Observing cancer’s progress in a mouse prostate March 14, 2019 Using a technique originally designed for mapping brains, two CSHL labs have worked together to image cancer progression in a mouse prostate.
Nation’s cancer centers endorse HPV vaccination June 8, 2018 Dr. Stillman and Dr. Tuveson joined with the leaders of other institutions nationwide in endorsing a statement regarding the HPV vaccine
Hannon named director of Cancer Research UK Cambridge Institute November 21, 2017 Dr. Greg Hannon has been named the new director of the Cancer Research UK Cambridge Institute, effective February 1, 2018.
Freeze-frames of enzymes in action have implications for a new cancer treatment concept July 3, 2017 TUTase enzymes interact with let-7, a regulator of development; targeting them could help control certain cancers.
A protein that stem cells require could be a target in killing breast cancer cells June 1, 2017 Cancer cells, like stem cells, have the ability to multiply indefinitely but epigenetic factor BPTF may be a shared weakness.
CSHL to lead international team developing next-generation organoid cancer research May 11, 2017 CSHL awarded a research subcontract by Leidos Biomedical Research to lead Cancer Model Development Center for upper-gastrointestinal cancers.
Newly discovered mutations impair key cell pathways in pancreatic cancer May 8, 2017 Researchers have found important new clues to the development of pancreatic cancer.
Pershing Square Sohn cancer research prize awarded to CSHL’s Dr. Mikala Egeblad May 8, 2017 Cold Spring Harbor Laboratory (CSHL) Associate Professor Mikala Egeblad, Ph.D., has been awarded the Pershing Square Sohn Prize.
New research explains why even targeted therapies eventually fail in lung cancer March 29, 2017 Dr. Sordella and her team propose a novel theory of how some cancers circumvent the killing power of targeted therapies.
Researchers identify “Achilles’ heel” of PTEN that helps drive prostate cancer progression February 13, 2017 Researchers at CSHL have discovered that a protein called Importin-11 protects the anti-cancer protein PTEN from destruction by transporting it.
Cancer research biobank formed by Northwell Health and Indivumed will enhance CSHL-Northwell alliance January 17, 2017 Northwell Health and Indivumed collaborate to greatly expand cancer biobanking activities within Northwell Health to develop medical approaches.
